Literature DB >> 15273090

DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones.

W P Giles1, A K Benson, M E Olson, R W Hutkins, J M Whichard, P L Winokur, P D Fey.   

Abstract

The emergence in the United States of resistance to expanded-spectrum cephalosporin (e.g., ceftriaxone) within the salmonellae has been associated primarily with three large (>100-kb) plasmids (designated types A, B, and C) and one 10.1-kb plasmid (type D) that carry the blaCMY-2 gene. In the present study, the distribution of these four known blaCMY-2-carrying plasmids among 35 ceftriaxone-resistant Salmonella isolates obtained from 1998 to 2001 was examined. Twenty-three of these isolates were Salmonella enterica serotype Newport, 10 were Salmonella enterica serotype Typhimurium, 1 was Salmonella enterica serotype Agona, and 1 was Salmonella enterica serotype Reading. All 23 serotype Newport isolates carried a type C plasmid, and 5, 4, and 1 serovar Typhimurium isolate carried type B, A, and C plasmids, respectively. Both the serotype Agona and serotype Reading isolates carried type A plasmids. None of the isolates carried a type D plasmid. Hybridization data suggested that plasmid types A and C were highly related replicons. DNA sequencing revealed that the region surrounding blaCMY-2 was highly conserved in all three plasmid types analyzed (types B, C, and D) and was related to a region surrounding blaCMY-5 from the Klebsiella oxytoca plasmid pTKH11. These findings are consistent with a model in which blaCMY-2 has been disseminated primarily through plasmid transfer, and not by mobilization of the gene itself, to multiple Salmonella chromosomal backbones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273090      PMCID: PMC478531          DOI: 10.1128/AAC.48.8.2845-2852.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998.

Authors:  A Carattoli; F Tosini; W P Giles; M E Rupp; S H Hinrichs; F J Angulo; T J Barrett; P D Fey
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene.

Authors:  Laurent Poirel; Jean-Winoc Decousser; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae.

Authors:  B Aserkoff; J V Bennett
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

Review 4.  Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae.

Authors:  N D Hanson; C C Sanders
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

5.  Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.

Authors:  P L Winokur; D L Vonstein; L J Hoffman; E K Uhlenhopp; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

6.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements.

Authors:  J J Dunn; F W Studier
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

7.  Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania.

Authors:  Shelley C Rankin; Helen Aceto; Jennifer Cassidy; Jeff Holt; Sheri Young; Brenda Love; Deepanker Tewari; Donald S Munro; Charles E Benson
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada.

Authors:  Kevin J Allen; Cornelius Poppe
Journal:  Can J Vet Res       Date:  2002-07       Impact factor: 1.310

9.  Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States.

Authors:  Amita Gupta; John Fontana; Colleen Crowe; Barbara Bolstorff; Alison Stout; Susan Van Duyne; Mike P Hoekstra; Jean M Whichard; Timothy J Barrett; Frederick J Angulo
Journal:  J Infect Dis       Date:  2003-11-18       Impact factor: 5.226

10.  Use of antibiotic susceptibility patterns and pulsed-field gel electrophoresis to compare historic and contemporary isolates of multi-drug-resistant Salmonella enterica subsp. enterica serovar Newport.

Authors:  Anna Catharina B Berge; John M Adaska; William M Sischo
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

View more
  37 in total

1.  Characterization of antimicrobial resistance of Salmonella Newport isolated from animals, the environment, and animal food products in Canada.

Authors:  Cornelius Poppe; Laura Martin; Anne Muckle; Marie Archambault; Scott McEwen; Emily Weir
Journal:  Can J Vet Res       Date:  2006-04       Impact factor: 1.310

2.  Cooccurrence of Multiple AmpC β-Lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in Tunisia.

Authors:  Thouraya Chérif; Mabrouka Saidani; Dominique Decré; Ilhem Boutiba-Ben Boubaker; Guillaume Arlet
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

3.  Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC.

Authors:  Shelley C Rankin; Jean M Whichard; Kevin Joyce; Lynn Stephens; Kathleen O'shea; Helen Aceto; Donald S Munro; Charles E Benson
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Variability in the region downstream of the blaCMY-2 beta-lactamase gene in Escherichia coli and Salmonella enterica plasmids.

Authors:  Min-Su Kang; Thomas E Besser; Douglas R Call
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Mode of transposition and expression of 16S rRNA methyltransferase gene rmtC accompanied by ISEcp1.

Authors:  Jun-ichi Wachino; Kunikazu Yamane; Kouji Kimura; Naohiro Shibata; Satowa Suzuki; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides.

Authors:  Jun-Ichi Wachino; Kunikazu Yamane; Keigo Shibayama; Hiroshi Kurokawa; Naohiro Shibata; Satowa Suzuki; Yohei Doi; Kouji Kimura; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

7.  CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.

Authors:  Marco M D'Andrea; Elisabetta Nucleo; Francesco Luzzaro; Tommaso Giani; Roberta Migliavacca; Francesca Vailati; Vesselina Kroumova; Laura Pagani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

8.  CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.

Authors:  A Zioga; J M Whichard; S D Kotsakis; L S Tzouvelekis; E Tzelepi; V Miriagou
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

9.  Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp. enterica serovar Newport and Escherichia coli in the turkey poult intestinal tract.

Authors:  C Poppe; L C Martin; C L Gyles; R Reid-Smith; P Boerlin; S A McEwen; J F Prescott; K R Forward
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

10.  First detection of AmpC β-lactamase bla(CMY-2) on a conjugative IncA/C plasmid in a Vibrio parahaemolyticus isolate of food origin.

Authors:  Ruichao Li; Dachuan Lin; Kaichao Chen; Marcus Ho Yin Wong; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.